Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia

NCT01859637 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Additional pharmacovigilance activity was considered as fulfilled by the EMA.

Conditions

Interventions

Sponsor

Sandoz

Collaborators